A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer

AIM: SMAD4 immunohistochemistry is considered a valuable prognostic marker in colorectal cancer, but individual studies have often been small and the results variable. A meta-analysis could potentially clarify these findings. METHODS: In September 2014, a Pubmed and Google Scholar search was conduc...

Full description

Bibliographic Details
Main Authors: Philip W. Voorneveld, MD, Rutger J. Jacobs, Liudmila L. Kodach, James C.H. Hardwick
Format: Article
Language:English
Published: Elsevier 2015-02-01
Series:Translational Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523314001247